OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress and prospect in tumor treating fields treatment of glioblastoma
Shiyu Liu, Weiyan Shi, Qin Zhao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111810-111810
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors
Li Zhang, Yue Liu, Haiyan Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114536-114536
Closed Access | Times Cited: 106

Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
Xiaoying Hou, Hongzhi Du, Yufei Deng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28

New insights into targeted therapy of glioblastoma using smart nanoparticles
Habib Ghaznavi, Reza Afzalipour, Samideh Khoei, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13

Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress
Zhuo Lü, Guifeng Sun, Kai-Yi He, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167220-167220
Closed Access | Times Cited: 11

Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
Baoqin Song, Xiu Wang, Lijing Qin, et al.
Pharmacological Research (2024) Vol. 206, pp. 107308-107308
Open Access | Times Cited: 6

Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study
Hao Wu, Lin Yang, Hanjie Liu, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 12, pp. 1587-1604
Open Access | Times Cited: 31

Research progress of anti-glioma chemotherapeutic drugs (Review)
Yi-Shu Zhou, Wei Wang, Na Chen, et al.
Oncology Reports (2022) Vol. 47, Iss. 5
Open Access | Times Cited: 22

Enhancing glioblastoma treatment through the integration of tumor-treating fields
Katarzyna Szklener, Mateusz Bilski, Karolina Nieoczym, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12

ABORDAGENS ATUAIS PARA DIAGNÓSTICO E PROGNÓSTICO DO GLIOBLASTOMA
Gustavo Haddad Souza Vieira, Isabella da Silva Freitas Goiozo, Vinícius Soares de Oliveira, et al.
Revista Foco (2025) Vol. 18, Iss. 1, pp. e7399-e7399
Open Access

Discovery of Noncovalent Diaminopyrimidine-based Inhibitors for Glioblastoma via a Dual FAK/DNA Targeting Strategy
Yi Wei, Xiaoling He, Zhiwu Long, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117288-117288
Closed Access

Immune Cell Interplay in the Fight Against GBM
Nico Vallieri, Angeliki Datsi
Cancers (2025) Vol. 17, Iss. 5, pp. 817-817
Open Access

Rotating electric Field in glioblastoma Therapy: A Novel Multi-Objective Node Adaptive Optimization Algorithm in TTFields
Liang Wang, Chunxiao Chen, Yueyue Xiao, et al.
Computers & Electrical Engineering (2025) Vol. 123, pp. 110223-110223
Closed Access

Research Progress in the Treatment of High-Grade Glioma in Recent Years
禹伯 董
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 2936-2946
Closed Access

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16

Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation
L Campana, Adil Daud, Francesco Lancellotti, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3340-3340
Open Access | Times Cited: 10

Glioblastoma: A molecular insight into current discoveries and treatment directions
Wiktor Świątek, Olgierd Kłodziński, Michał Ciesielski, et al.
Medical Journal of Cell Biology (2024) Vol. 12, Iss. 1, pp. 1-20
Open Access | Times Cited: 2

Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
Huan Li, Chao Song, Yang Zhang, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 6

Siderol Inhibits Proliferation of Glioblastoma Cells and Acts Synergistically with Temozolomide
Maria Giannakopoulou, Kiriakos Dimitriadis, M Koromili, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3216-3216
Open Access | Times Cited: 9

Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy
Ana R. Neves, Tânia Albuquerque, Rúben Faria, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2213-2213
Open Access | Times Cited: 8

Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
Harshit Arora, Marco Mammi, Naisargi Manishkumar Patel, et al.
Journal of Neuro-Oncology (2023) Vol. 166, Iss. 1, pp. 17-26
Closed Access | Times Cited: 4

Personalized optimization strategy for electrode array layout in TTFields of glioblastoma
Liang Wang, Chunxiao Chen, Yueyue Xiao, et al.
International Journal for Numerical Methods in Biomedical Engineering (2024) Vol. 40, Iss. 10
Closed Access | Times Cited: 1

Synergistic Anti-Cancer Effects of Isocnicin and Radiotherapy in Glioblastoma: A Natural Compound’s Potential
Effrosyni Tsafa, Kyriakos Dimitriadis, Lamprini Kalampoki, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2793-2793
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top